Vaccines — Business MegaBrands 2026–27
Indian vaccine manufacturers develop and produce vaccines for routine childhood immunisation, outbreak response and adult use, supplying the national immunisation effort, private healthcare and international agencies. Production requires biological manufacturing, cold-chain handling and lot-by-lot regulatory release. The category underpins public health efforts in India and makes the country a supplier of vaccines to many lower-income countries.
Slot BMB-178 · Biologics & Vaccines · 5 brands in contention · Business MegaBrand: to be announced in 2027
Brands in contention
Listed alphabetically. The order does not reflect evaluation.
| Company | MegaBrands 501 |
|---|---|
| Bharat Biotech | |
| Biological E | |
| Indian Immunologicals | |
| Panacea Biotec | |
| Serum Institute of India | Also a MegaBrand 501 |
How this category is evaluated
Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology
Frequently asked
Which are the leading vaccine manufacturers in India?
In the Business MegaBrands 2026–27 cohort, the brands in contention for vaccines are Bharat Biotech, Biological E, Indian Immunologicals, Panacea Biotec and Serum Institute of India. This is a list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation of every brand in contention.
Other categories in Biologics & Vaccines
All of Pharma, Life Sciences & Medtech · The 2026–27 cohort
Cite this page: WCRC, Business MegaBrands 2026–27, Vaccines (Slot BMB-178), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/vaccines/, accessed [date].
WCRC network: WCRC International · WCRC Leaders